358 related articles for article (PubMed ID: 15647189)
21. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
22. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial.
Jain PK; McNaught CE; Anderson AD; MacFie J; Mitchell CJ
Clin Nutr; 2004 Aug; 23(4):467-75. PubMed ID: 15297081
[TBL] [Abstract][Full Text] [Related]
23. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Astó E; Méndez I; Audivert S; Farran-Codina A; Espadaler J
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30704039
[TBL] [Abstract][Full Text] [Related]
24. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.
Wehkamp J; Harder J; Weichenthal M; Mueller O; Herrlinger KR; Fellermann K; Schroeder JM; Stange EF
Inflamm Bowel Dis; 2003 Jul; 9(4):215-23. PubMed ID: 12902844
[TBL] [Abstract][Full Text] [Related]
25. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy.
Joo M; Odze RD
Am J Surg Pathol; 2010 May; 34(5):689-96. PubMed ID: 20410806
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis.
Ng SC; Plamondon S; Kamm MA; Hart AL; Al-Hassi HO; Guenther T; Stagg AJ; Knight SC
Inflamm Bowel Dis; 2010 Aug; 16(8):1286-98. PubMed ID: 20155842
[TBL] [Abstract][Full Text] [Related]
27. Mucosal adhesion and anti-inflammatory effects of
Pagnini C; Corleto VD; Martorelli M; Lanini C; D'Ambra G; Di Giulio E; Delle Fave G
World J Gastroenterol; 2018 Nov; 24(41):4652-4662. PubMed ID: 30416313
[TBL] [Abstract][Full Text] [Related]
28. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
[TBL] [Abstract][Full Text] [Related]
29. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis.
Wildt S; Nordgaard I; Hansen U; Brockmann E; Rumessen JJ
J Crohns Colitis; 2011 Apr; 5(2):115-21. PubMed ID: 21453880
[TBL] [Abstract][Full Text] [Related]
30. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer.
Worthley DL; Le Leu RK; Whitehall VL; Conlon M; Christophersen C; Belobrajdic D; Mallitt KA; Hu Y; Irahara N; Ogino S; Leggett BA; Young GP
Am J Clin Nutr; 2009 Sep; 90(3):578-86. PubMed ID: 19640954
[TBL] [Abstract][Full Text] [Related]
31. Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis.
Bai AP; Ouyang Q; Xiao XR; Li SF
Int J Clin Pract; 2006 Mar; 60(3):284-8. PubMed ID: 16494642
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of mucosal beta-defensin-2, TNFalpha and IL-1beta in ulcerative colitis].
Chang YY; Ouyang Q
Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):11-4. PubMed ID: 18346318
[TBL] [Abstract][Full Text] [Related]
33. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
34. Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis.
Jadhav A; Jagtap S; Vyavahare S; Sharbidre A; Kunchiraman B
Front Cell Infect Microbiol; 2023; 13():1268041. PubMed ID: 38145046
[TBL] [Abstract][Full Text] [Related]
35. Chronic HIV Infection Is Associated with Upregulation of Proinflammatory Cytokine and Chemokine and Alpha Defensin Gene Expression in Colorectal Mucosa.
Mait-Kaufman J; Fakioglu E; Mesquita PM; Elliott J; Lo Y; Madan RP
AIDS Res Hum Retroviruses; 2015 Jun; 31(6):615-22. PubMed ID: 25768924
[TBL] [Abstract][Full Text] [Related]
36. Wild-type and IL10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifidobacterium animalis subspecies lactis and inulin.
Kuo SM; Chan WC; Hu Z
J Nutr; 2014 Mar; 144(3):245-51. PubMed ID: 24381223
[TBL] [Abstract][Full Text] [Related]
37. Oral engineered Bifidobacterium longum expressing rhMnSOD to suppress experimental colitis.
Liu M; Li S; Zhang Q; Xu Z; Wang J; Sun H
Int Immunopharmacol; 2018 Apr; 57():25-32. PubMed ID: 29455070
[TBL] [Abstract][Full Text] [Related]
38. Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study.
Agraib LM; Yamani MI; Tayyem R; Abu-Sneineh AT; Rayyan YM
Clin Nutr ESPEN; 2022 Oct; 51():83-91. PubMed ID: 36184252
[TBL] [Abstract][Full Text] [Related]
39. Attenuated GABAergic Signaling in Intestinal Epithelium Contributes to Pathogenesis of Ulcerative Colitis.
Aggarwal S; Ahuja V; Paul J
Dig Dis Sci; 2017 Oct; 62(10):2768-2779. PubMed ID: 28667430
[TBL] [Abstract][Full Text] [Related]
40. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study.
Huynh HQ; deBruyn J; Guan L; Diaz H; Li M; Girgis S; Turner J; Fedorak R; Madsen K
Inflamm Bowel Dis; 2009 May; 15(5):760-8. PubMed ID: 19067432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
